SEC Company Response from Beyond Air, Inc. (XAIR) (CIK 0001641631) (XAIR) — May 7, 2018
Beyond Air, Inc. (XAIR) (CIK 0001641631)
Date: May 7, 2018 · CIK: 0001641631 · Accession: 0001178913-18-001493
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-223988
Letter
VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Attention: Tom Jones AIT Therapeutics, Inc. Registration Statement on Form S-1, as amended Filed March 28, 2018 File No. 333-223988
Dear Mr. Jones:
On behalf of AIT Therapeutics, Inc. (the “Company”) and pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, the undersigned hereby requests that the effective date of the above-referenced Registration Statement on Form S-1, as amended, be accelerated to 4:00 p.m., Washington, D.C. time, on May 9, 2018, or as soon as practicable thereafter, unless the Company notifies you otherwise prior to such time.
Once the Registration Statement has been declared effective, we respectfully request that you orally confirm that event with our counsel, Latham & Watkins LLP, by calling Peter N. Handrinos at (617) 948-6060 or Brandon Bortner at (202) 637-2117.
If you have any questions regarding the foregoing, please do not hesitate to contact Peter N. Handrinos at (617) 948-6060 or Brandon Bortner at (202) 637-2117, of Latham & Watkins LLP. Thank you in advance for your consideration.
AIT THERAPEUTICS, INC.
By: /s/ Steven Lisi
Name: Steven Lisi
Title: Chief Executive Officer and Chairman of the Board of Directors
cc: Peter N. Handrinos, Latham & Watkins LLP
Brandon Bortner, Latham & Watkins LLP
Show Raw Text
CORRESP
1
filename1.htm
AIT THERAPEUTICS, INC.
500 Mamaroneck Avenue, Suite 320
Harrison, NY 10528
May 7, 2018
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Tom Jones
Re:
AIT Therapeutics, Inc.
Registration Statement on Form S-1, as amended
Filed March 28, 2018
File No. 333-223988
Dear Mr. Jones:
On behalf of AIT Therapeutics, Inc. (the “Company”) and pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, the undersigned hereby requests that the effective date of the above-referenced Registration Statement on Form S-1, as amended, be accelerated to 4:00 p.m., Washington, D.C. time, on May 9, 2018, or as soon as practicable thereafter, unless the Company notifies you otherwise prior to such time.
Once the Registration Statement has been declared effective, we respectfully request that you orally confirm that event with our counsel, Latham & Watkins LLP, by calling Peter N. Handrinos at (617) 948-6060 or Brandon Bortner at (202) 637-2117.
If you have any questions regarding the foregoing, please do not hesitate to contact Peter N. Handrinos at (617) 948-6060 or Brandon Bortner at (202) 637-2117, of Latham & Watkins LLP. Thank you in advance for your consideration.
AIT THERAPEUTICS, INC.
By: /s/ Steven Lisi
Name: Steven Lisi
Title: Chief Executive Officer and Chairman of the Board of Directors
cc: Peter N. Handrinos, Latham & Watkins LLP
Brandon Bortner, Latham & Watkins LLP